Table of Content

1 INTRODUCTION 40
1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 40
1.3 MARKET SCOPE 41
1.3.1 MARKETS COVERED 41
FIGURE 1 BRAIN MONITORING MARKET SEGMENTATION 41
1.3.2 YEARS CONSIDERED FOR THE STUDY 42
1.4 CURRENCY 42
1.5 LIMITATIONS 42
1.6 STAKEHOLDERS 43
1.7 SUMMARY OF CHANGES 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 2 RESEARCH DESIGN 44
2.1.1 SECONDARY SOURCES 45
2.1.1.1 Key data from secondary sources 45
2.1.2 PRIMARY DATA 46
FIGURE 3 PRIMARY SOURCES 46
2.1.2.1 Key data from primary sources 47
2.1.2.2 Insights from primary experts 47
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 48
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS 48
2.2 MARKET SIZE ESTIMATION 48
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 49
FIGURE 7 COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION: BRAIN MONITORING MARKET 50
FIGURE 8 COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION: EEG MARKET 50
FIGURE 9 TOP-DOWN APPROACH 52
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE BRAIN MONITORING MARKET (2021–2026) 53
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 54
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 55
FIGURE 12 DATA TRIANGULATION METHODOLOGY 55
2.4 MARKET SHARE ESTIMATION 56
2.5 ASSUMPTIONS FOR THE STUDY 56
2.6 RISK ASSESSMENT 57
TABLE 1 RISK ASSESSMENT: BRAIN MONITORING MARKET 57
3 EXECUTIVE SUMMARY 58
FIGURE 13 BRAIN MONITORING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 58
FIGURE 14 BRAIN MONITORING DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 59
FIGURE 15 BRAIN MONITORING MARKET, BY MEDICAL CONDITION,
2021 VS. 2026 (USD MILLION) 59
FIGURE 16 BRAIN MONITORING MARKET, BY END USER, 2021–2026 (USD MILLION) 60
FIGURE 17 BRAIN MONITORING MARKET: GEOGRAPHIC SNAPSHOT 60
4 PREMIUM INSIGHTS 62
4.1 BRAIN MONITORING MARKET OVERVIEW 62
FIGURE 18 INCREASING INCIDENCE AND PREVALENCE OF NEUROLOGICAL DISORDERS?A MAJOR FACTOR DRIVING MARKET GROWTH 62
4.2 BRAIN MONITORING MARKET, BY PRODUCT 63
FIGURE 19 DEVICES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD (2021–2026) 63
4.3 BRAIN MONITORING MARKET, BY END USER 63
FIGURE 20 HOSPITALS HELD THE LARGEST SHARE OF THE END-USER MARKET IN 2020 63
4.4 GEOGRAPHIC SNAPSHOT OF THE GLOBAL BRAIN MONITORING MARKET 64
FIGURE 21 MARKETS IN THE APAC AND ROW WILL REGISTER HIGH GROWTH RATES DURING THE FORECAST PERIOD 64
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
5.2 MARKET DYNAMICS 65
FIGURE 22 BRAIN MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65
5.2.1 DRIVERS 66
5.2.1.1 Increasing incidence and prevalence of neurological disorders 66
5.2.1.2 Rising awareness of neurodegenerative disorders 66
5.2.1.3 Growing incidence of traumatic brain injuries 67
5.2.1.4 Increasing applications in clinical trials 67
5.2.2 RESTRAINTS 68
5.2.2.1 High cost of complex brain monitoring procedures and devices 68
5.2.2.2 Unfavorable reimbursement policies 68
5.2.3 OPPORTUNITIES 69
5.2.3.1 Increasing demand for non-invasive and minimally invasive devices 69
5.2.3.2 Expanding therapeutic applications of brain monitoring devices 69
5.2.3.3 Growing healthcare market in emerging economies 70
FIGURE 23 GLOBAL ANNUAL HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING ECONOMIES (1995 VS. 2012 VS. 2022) 70
5.2.4 CHALLENGES 71
5.2.4.1 Shortage of trained professionals 71
5.2.4.2 Issues related to product approval and commercialization 71
5.3 IMPACT OF COVID-19 ON THE BRAIN MONITORING MARKET 72
5.4 PRICING ANALYSIS 73
TABLE 2 REGIONAL PRICING ANALYSIS OF KEY BRAIN MONITORING MODALITIES 73
5.5 VALUE CHAIN ANALYSIS 73
5.5.1 RESEARCH & DEVELOPMENT 73
5.5.2 MANUFACTURING & ASSEMBLY 73
5.5.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 73
FIGURE 24 VALUE CHAIN ANALYSIS 74
5.6 ECOSYSTEM ANALYSIS 74
5.7 PORTER’S FIVE FORCES ANALYSIS 75
TABLE 3 BRAIN MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS 75
5.8 REGULATORY LANDSCAPE 75
5.8.1 NORTH AMERICA 75
5.8.1.1 US 75
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION 75
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76
5.8.1.2 Canada 76
5.8.2 EUROPE 76
5.8.3 ASIA PACIFIC 77
5.8.3.1 Japan 77
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 77
5.8.3.2 China 78
5.8.3.3 India 79
5.9 PATENT ANALYSIS 79
FIGURE 25 MAJOR PATENT HOLDERS FOR MRI DEVICES (JANUARY 2011–MAY 2021) 79
FIGURE 26 MAJOR PATENT HOLDERS FOR CT SCANNERS (JANUARY 2011–MAY 2021) 80
FIGURE 27 MAJOR PATENT HOLDERS FOR PET SCANNERS (JANUARY 2011–MAY 2021) 80
6 BRAIN MONITORING MARKET, BY PRODUCT 81
6.1 INTRODUCTION 82
TABLE 7 BRAIN MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 82
6.2 DEVICES 82
TABLE 8 BRAIN MONITORING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 83
TABLE 9 NORTH AMERICA: BRAIN MONITORING DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 83
TABLE 10 EUROPE: BRAIN MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 83
TABLE 11 APAC: BRAIN MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 84
6.2.1 BRAIN MONITORING DEVICES MARKET, BY TYPE 84
TABLE 12 BRAIN MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 84
TABLE 13 BRAIN MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (UNITS) 85
6.2.1.1 MRI scanners 85
6.2.1.1.1 Research efforts focusing on technological advancements like AI for image analysis will drive market growth 85
TABLE 14 MRI SCANNERS MARKET, BY REGION, 2019–2026 (USD MILLION) 86
TABLE 15 NORTH AMERICA: MRI SCANNERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 86
TABLE 16 EUROPE: MRI SCANNERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 86
TABLE 17 APAC: MRI SCANNERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 87
6.2.1.2 CT scanners 87
6.2.1.2.1 High preference for CT among physicians for brain disease progression monitoring to drive market growth 87
TABLE 18 CT SCANNERS MARKET, BY REGION, 2019–2026 (USD MILLION) 87
TABLE 19 NORTH AMERICA: CT SCANNERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 88
TABLE 20 EUROPE: CT SCANNERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 88
TABLE 21 APAC: CT SCANNERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 88
6.2.1.3 EEG devices 89
6.2.1.3.1 Growing applications of EEG and the rising number of specialized facilities are the key growth drivers for this market 89
TABLE 22 EEG DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 89
TABLE 23 EEG DEVICES MARKET, BY REGION, 2019–2026 (UNITS) 90
TABLE 24 NORTH AMERICA: EEG DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 90
TABLE 25 EUROPE: EEG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 90
TABLE 26 APAC: EEG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 91
TABLE 27 EEG DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 91
6.2.1.4 PET scanners 91
6.2.1.4.1 Introduction of novel radiopharmaceutical tracers has driven the use of PET in brain disease monitoring 91
TABLE 28 PET SCANNERS MARKET, BY REGION, 2019–2026 (USD MILLION) 92
TABLE 29 NORTH AMERICA: PET SCANNERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 92
TABLE 30 EUROPE: PET SCANNERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 92
TABLE 31 APAC: PET SCANNERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 93
6.2.1.5 Sleep monitoring devices 93
6.2.1.5.1 Rising incidence of sleep disorders is boosting the demand for sleep monitoring devices 93
TABLE 32 SLEEP MONITORING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 93
TABLE 33 SLEEP MONITORING DEVICES MARKET, BY REGION, 2019–2026 (UNITS) 94
TABLE 34 NORTH AMERICA: SLEEP MONITORING DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 94
TABLE 35 EUROPE: SLEEP MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 94
TABLE 36 APAC: SLEEP MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 95
6.2.1.6 Cerebral oximeters 95
6.2.1.6.1 Growing cases of hypoxia during surgical procedures are likely to drive market growth 95
TABLE 37 CEREBRAL OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION) 95
TABLE 38 CEREBRAL OXIMETERS MARKET, BY REGION, 2019–2026 (UNITS) 96
TABLE 39 NORTH AMERICA: CEREBRAL OXIMETERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 96
TABLE 40 EUROPE: CEREBRAL OXIMETERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 96
TABLE 41 APAC: CEREBRAL OXIMETERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 97
6.2.1.7 EMG devices 97
6.2.1.7.1 High demand for EMG devices is mainly due to the increasing prevalence of neuromuscular diseases 97
TABLE 42 EMG DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 97
TABLE 43 EMG DEVICES MARKET, BY REGION, 2019–2026 (UNITS) 98
TABLE 44 NORTH AMERICA: EMG DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 98
TABLE 45 EUROPE: EMG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 98
TABLE 46 APAC: EMG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 99
6.2.1.8 ICP monitors 99
6.2.1.8.1 Fatal consequences of high ICP make monitoring important 99
TABLE 47 ICP MONITORS MARKET, BY REGION, 2019–2026 (USD MILLION) 99
TABLE 48 ICP MONITORS MARKET, BY REGION, 2019–2026 (UNITS) 100
TABLE 49 NORTH AMERICA: ICP MONITORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 100
TABLE 50 EUROPE: ICP MONITORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 100
TABLE 51 APAC: ICP MONITORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 101
6.2.1.9 MEG devices 101
6.2.1.9.1 High implementation and maintenance costs of MEG devices are likely to hinder market growth 101
TABLE 52 MEG DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 101
TABLE 53 MEG DEVICES MARKET, BY REGION, 2019–2026 (UNITS) 102
TABLE 54 NORTH AMERICA: MEG DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 102
TABLE 55 EUROPE: MEG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 102
TABLE 56 APAC: MEG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 103
6.2.1.10 TCD devices 103
6.2.1.10.1 Rising prevalence of strokes and cerebrovascular disorders will contribute to market growth 103
TABLE 57 TCD DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 103
TABLE 58 TCD DEVICES MARKET, BY REGION, 2019–2026 (UNITS) 104
TABLE 59 NORTH AMERICA: TCD DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 104
TABLE 60 EUROPE: TCD DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 104
TABLE 61 APAC: TCD DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
6.2.2 BRAIN MONITORING DEVICES MARKET, BY PROCEDURE 105
TABLE 62 BRAIN MONITORING DEVICES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 105
6.2.2.1 Devices for non-invasive procedures 105
6.2.2.1.1 Drawbacks of invasive monitoring are driving the demand for devices for non-invasive procedures 105
TABLE 63 BRAIN MONITORING DEVICES MARKET FOR NON-INVASIVE PROCEDURES, BY REGION, 2019–2026 (USD MILLION) 106
TABLE 64 NORTH AMERICA: BRAIN MONITORING DEVICES MARKET FOR NON-INVASIVE PROCEDURES, BY COUNTRY, 2019–2026 (USD MILLION) 106
TABLE 65 EUROPE: BRAIN MONITORING DEVICES MARKET FOR NON-INVASIVE PROCEDURES, BY COUNTRY, 2019–2026 (USD MILLION) 106
TABLE 66 APAC: BRAIN MONITORING DEVICES MARKET FOR NON-INVASIVE PROCEDURES, BY COUNTRY, 2019–2026 (USD MILLION) 107
6.2.2.2 Devices for invasive procedures 107
6.2.2.2.1 Higher accuracy of devices used for invasive procedures has ensured their adoption 107
TABLE 67 BRAIN MONITORING DEVICES MARKET FOR INVASIVE PROCEDURES, BY REGION, 2019–2026 (USD MILLION) 107
TABLE 68 NORTH AMERICA: BRAIN MONITORING DEVICES MARKET FOR INVASIVE PROCEDURES, BY COUNTRY, 2019–2026 (USD MILLION) 108
TABLE 69 EUROPE: BRAIN MONITORING DEVICES MARKET FOR INVASIVE PROCEDURES, BY COUNTRY, 2019–2026 (USD MILLION) 108
TABLE 70 APAC: BRAIN MONITORING DEVICES MARKET FOR INVASIVE PROCEDURES, BY COUNTRY, 2019–2026 (USD MILLION) 108
6.3 ACCESSORIES 109
TABLE 71 BRAIN MONITORING ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION) 109
TABLE 72 NORTH AMERICA: BRAIN MONITORING ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 109
TABLE 73 EUROPE: BRAIN MONITORING ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 110
TABLE 74 APAC: BRAIN MONITORING ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 110
6.3.1 BRAIN MONITORING ACCESSORIES MARKET, BY TYPE 110
TABLE 75 BRAIN MONITORING ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 110
TABLE 76 BRAIN MONITORING ACCESSORIES MARKET, BY TYPE,
2019–2026 (THOUSAND UNITS) 111
6.3.1.1 Electrodes 111
TABLE 77 ELECTRODES MARKET, BY REGION, 2019–2026 (USD MILLION) 111
TABLE 78 ELECTRODES MARKET, BY REGION, 2019–2026 (THOUSAND UNITS) 112
TABLE 79 NORTH AMERICA: ELECTRODES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 112
TABLE 80 EUROPE: ELECTRODES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 112
TABLE 81 APAC: ELECTRODES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 113
6.3.1.1.1 Electrodes market, by type 113
TABLE 82 ELECTRODES MARKET, BY TYPE, 2019–2026 (USD MILLION) 113
6.3.1.1.1.1 Wet electrodes 113
6.3.1.1.1.1.1 Flexibility and high quality of signal recording are driving the adoption of wet electrodes 113
TABLE 83 WET ELECTRODES MARKET, BY REGION, 2019–2026 (USD MILLION) 114
6.3.1.1.1.2 Dry electrodes 114
6.3.1.1.1.2.1 Technological advancements and non-requirement for skin preparation have made dry electrodes popular 114
TABLE 84 DRY ELECTRODES MARKET, BY REGION, 2019–2026 (USD MILLION) 114
6.3.1.1.1.3 Needle electrodes 114
6.3.1.1.1.3.1 Needle electrodes can provide more accurate signals for disease assessment 114
TABLE 85 NEEDLE ELECTRODES MARKET, BY REGION, 2019–2026 (USD MILLION) 115
6.3.1.2 Sensors 115
6.3.1.2.1 Increasing patient preference for non-invasive procedures to drive the market for sensors 115
TABLE 86 SENSORS MARKET, BY REGION, 2019–2026 (USD MILLION) 115
TABLE 87 SENSORS MARKET, BY REGION, 2019–2026 (THOUSAND UNITS) 116
TABLE 88 NORTH AMERICA: SENSORS MARKET, BY REGION,
2019–2026 (USD MILLION) 116
TABLE 89 EUROPE: SENSORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 116
TABLE 90 APAC: SENSORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 117
6.3.1.3 Pastes & gels 117
6.3.1.3.1 Development of novel gels & pastes is likely to drive market growth 117
TABLE 91 PASTES & GELS MARKET, BY REGION, 2019–2026 (USD MILLION) 117
TABLE 92 PASTES & GELS MARKET, BY REGION, 2019–2026 (THOUSAND UNITS) 118
TABLE 93 NORTH AMERICA: PASTES & GELS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 118
TABLE 94 EUROPE: PASTES & GELS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 118
TABLE 95 APAC: PASTES & GELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 119
6.3.1.4 Caps 119
6.3.1.4.1 Extended application of Infacaps for premature babies to offer new opportunities for market players 119
TABLE 96 CAPS MARKET, BY REGION, 2019–2026 (USD MILLION) 119
TABLE 97 CAPS MARKET, BY REGION, 2019–2026 (THOUSAND UNITS) 120
TABLE 98 NORTH AMERICA: CAPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 120
TABLE 99 EUROPE: CAPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 120
TABLE 100 APAC: CAPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
6.3.1.5 Batteries 121
6.3.1.5.1 Increasing usage of portable devices will drive market growth 121
TABLE 101 BATTERIES MARKET, BY REGION, 2019–2026 (USD MILLION) 121
TABLE 102 BATTERIES MARKET, BY REGION, 2019–2026 (THOUSAND UNITS) 122
TABLE 103 NORTH AMERICA: BATTERIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 122
TABLE 104 EUROPE: BATTERIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
TABLE 105 APAC: BATTERIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 123
6.3.1.6 Cables 123
6.3.1.6.1 Technological developments for increasing the capabilities and lifespan of cables will drive market growth 123
TABLE 106 CABLES MARKET, BY REGION, 2019–2026 (USD MILLION) 123
TABLE 107 CABLES MARKET, BY REGION, 2019–2026 (THOUSAND UNITS) 124
TABLE 108 NORTH AMERICA: CABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
TABLE 109 EUROPE: CABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 124
TABLE 110 APAC: CABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 125
6.3.1.7 Other accessories 125
TABLE 111 OTHER BRAIN MONITORING ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION) 125
TABLE 112 NORTH AMERICA: OTHER BRAIN MONITORING ACCESSORIES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 125
TABLE 113 EUROPE: OTHER BRAIN MONITORING ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 126
TABLE 114 APAC: OTHER BRAIN MONITORING ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 126
6.3.2 BRAIN MONITORING ACCESSORIES MARKET, BY USABILITY 126
TABLE 115 BRAIN MONITORING ACCESSORIES MARKET, BY USABILITY,
2019–2026 (USD MILLION) 126
6.3.2.1 Disposable accessories 127
6.3.2.1.1 Growing physician preference for disposable accessories is driving market growth 127
TABLE 116 DISPOSABLE ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION) 127
TABLE 117 NORTH AMERICA: DISPOSABLE ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 127
TABLE 118 EUROPE: DISPOSABLE ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 128
TABLE 119 APAC: DISPOSABLE ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 128
6.3.2.2 Reusable accessories 128
6.3.2.2.1 High usage of reusable accessories in developing countries will drive market growth 128
TABLE 120 REUSABLE ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION) 129
TABLE 121 NORTH AMERICA: REUSABLE ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
TABLE 122 EUROPE: REUSABLE ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
TABLE 123 APAC: REUSABLE ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 130
7 BRAIN MONITORING MARKET, BY MEDICAL CONDITION 131
7.1 INTRODUCTION 132
TABLE 124 BRAIN MONITORING MARKET, BY MEDICAL CONDITION,
2019–2026 (USD MILLION) 132
7.2 TRAUMATIC BRAIN INJURY 132
7.2.1 GROWING INCIDENCE OF TBI ACROSS THE GLOBE TO DRIVE MARKET GROWTH 132
TABLE 125 BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURY, BY REGION, 2019–2026 (USD MILLION) 133
TABLE 126 NORTH AMERICA: BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURY, BY COUNTRY, 2019–2026 (USD MILLION) 133
TABLE 127 EUROPE: BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURY, BY COUNTRY, 2019–2026 (USD MILLION) 133
TABLE 128 APAC: BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURY, BY COUNTRY, 2019–2026 (USD MILLION) 134
7.3 STROKE 134
7.3.1 GROWING AWARENESS ABOUT STROKES AND THEIR TREATMENT OPTIONS TO SUPPORT MARKET GROWTH 134
TABLE 129 BRAIN MONITORING MARKET FOR STROKE, BY REGION,
2019–2026 (USD MILLION) 134
TABLE 130 NORTH AMERICA: BRAIN MONITORING MARKET FOR STROKE, BY COUNTRY, 2019–2026 (USD MILLION) 135
TABLE 131 EUROPE: BRAIN MONITORING MARKET FOR STROKE, BY COUNTRY,
2019–2026 (USD MILLION) 135
TABLE 132 APAC: BRAIN MONITORING MARKET FOR STROKE, BY COUNTRY,
2019–2026 (USD MILLION) 135
7.4 DEMENTIA 136
7.4.1 GOVERNMENT INITIATIVES TO PROMOTE AWARENESS OF DEMENTIA?A MAJOR FACTOR DRIVING MARKET GROWTH 136
TABLE 133 BRAIN MONITORING MARKET FOR DEMENTIA, BY REGION,
2019–2026 (USD MILLION) 136
TABLE 134 NORTH AMERICA: BRAIN MONITORING MARKET FOR DEMENTIA, BY COUNTRY, 2019–2026 (USD MILLION) 136
TABLE 135 EUROPE: BRAIN MONITORING MARKET FOR DEMENTIA, BY COUNTRY,
2019–2026 (USD MILLION) 137
TABLE 136 APAC: BRAIN MONITORING MARKET FOR DEMENTIA, BY COUNTRY,
2019–2026 (USD MILLION) 137
7.5 HEADACHE DISORDERS 137
7.5.1 NEUROIMAGING TECHNIQUES ARE USED FOR THE EVALUATION OF HEADACHE DISORDERS IN CLINICAL PRACTICES 137
TABLE 137 BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY REGION, 2019–2026 (USD MILLION) 138
TABLE 138 NORTH AMERICA: BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY COUNTRY, 2019–2026 (USD MILLION) 138
TABLE 139 EUROPE: BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY COUNTRY, 2019–2026 (USD MILLION) 138
TABLE 140 APAC: BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY COUNTRY, 2019–2026 (USD MILLION) 139
7.6 SLEEP DISORDERS 139
7.6.1 GROWING INCIDENCE OF SLEEP DISORDERS TO DRIVE MARKET GROWTH 139
TABLE 141 BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY REGION,
2019–2026 (USD MILLION) 140
TABLE 142 NORTH AMERICA: BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2019–2026 (USD MILLION) 140
TABLE 143 EUROPE: BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2019–2026 (USD MILLION) 140
TABLE 144 APAC: BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2019–2026 (USD MILLION) 141
7.7 PARKINSON’S DISEASE 141
7.7.1 INCREASING PREVALENCE OF PARKINSON’S DISEASE TO DRIVE MARKET GROWTH 141
TABLE 145 BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY REGION, 2019–2026 (USD MILLION) 141
TABLE 146 NORTH AMERICA: BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2019–2026 (USD MILLION) 142
TABLE 147 EUROPE: BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2019–2026 (USD MILLION) 142
TABLE 148 APAC: BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2019–2026 (USD MILLION) 142
7.8 EPILEPSY 143
7.8.1 LARGE POPULATION DEPRIVED OF ACCURATE TREATMENT FOR EPILEPSY TO OFFER GROWTH OPPORTUNITIES FOR MARKET PLAYERS 143
TABLE 149 BRAIN MONITORING MARKET FOR EPILEPSY, BY REGION,
2019–2026 (USD MILLION) 143
TABLE 150 NORTH AMERICA: BRAIN MONITORING MARKET FOR EPILEPSY, BY COUNTRY, 2019–2026 (USD MILLION) 144
TABLE 151 EUROPE: BRAIN MONITORING MARKET FOR EPILEPSY, BY COUNTRY,
2019–2026 (USD MILLION) 144
TABLE 152 APAC: BRAIN MONITORING MARKET FOR EPILEPSY, BY COUNTRY,
2019–2026 (USD MILLION) 144
7.9 HUNTINGTON’S DISEASE 145
7.9.1 AVAILABILITY OF ADVANCED METHODOLOGIES FOR DIAGNOSIS TO AID MARKET GROWTH 145
TABLE 153 BRAIN MONITORING MARKET FOR HUNTINGTON’S DISEASE, BY REGION, 2019–2026 (USD MILLION) 145
TABLE 154 NORTH AMERICA: BRAIN MONITORING MARKET FOR HUNTINGTON’S DISEASE, BY COUNTRY, 2019–2026 (USD MILLION) 145
TABLE 155 EUROPE: BRAIN MONITORING MARKET FOR HUNTINGTON’S DISEASE, BY COUNTRY, 2019–2026 (USD MILLION) 146
TABLE 156 APAC: BRAIN MONITORING MARKET FOR HUNTINGTON’S DISEASE, BY COUNTRY, 2019–2026 (USD MILLION) 146
7.10 OTHER MEDICAL CONDITIONS 146
TABLE 157 BRAIN MONITORING MARKET FOR OTHER MEDICAL CONDITIONS, BY REGION, 2019–2026 (USD MILLION) 147
TABLE 158 NORTH AMERICA: BRAIN MONITORING MARKET FOR OTHER MEDICAL CONDITIONS, BY COUNTRY, 2019–2026 (USD MILLION) 147
TABLE 159 EUROPE: BRAIN MONITORING MARKET FOR OTHER MEDICAL CONDITIONS, BY COUNTRY, 2019–2026 (USD MILLION) 147
TABLE 160 APAC: BRAIN MONITORING MARKET FOR OTHER MEDICAL CONDITIONS, BY COUNTRY, 2019–2026 (USD MILLION) 148
8 BRAIN MONITORING MARKET, BY END USER 149
8.1 INTRODUCTION 150
TABLE 161 BRAIN MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION) 150
8.2 HOSPITALS 150
8.2.1 HOSPITALS ARE THE MAJOR END USERS OF BRAIN MONITORING DEVICES 150
TABLE 162 BRAIN MONITORING MARKET FOR HOSPITALS, BY REGION,
2019–2026 (USD MILLION) 151
TABLE 163 NORTH AMERICA: BRAIN MONITORING MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION) 151
TABLE 164 EUROPE: BRAIN MONITORING MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION) 151
TABLE 165 APAC: BRAIN MONITORING MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 152
8.3 NEUROLOGY CENTERS 152
8.3.1 PREFERENCE FOR THE DIAGNOSIS AND TREATMENT OF BRAIN DISORDERS AT NEUROLOGY CENTERS IS INCREASING AMONG PATIENTS 152
TABLE 166 BRAIN MONITORING MARKET FOR NEUROLOGY CENTERS, BY REGION, 2019–2026 (USD MILLION) 152
TABLE 167 NORTH AMERICA: BRAIN MONITORING MARKET FOR NEUROLOGY CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 153
TABLE 168 EUROPE: BRAIN MONITORING MARKET FOR NEUROLOGY CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 153
TABLE 169 APAC: BRAIN MONITORING MARKET FOR NEUROLOGY CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 153
8.4 AMBULATORY SURGERY CENTERS & CLINICS 154
8.4.1 PATIENTS ARE INCREASINGLY OPTING FOR AMBULATORY SURGERY CENTERS & CLINICS AS A MORE CONVENIENT ALTERNATIVE TO HOSPITAL-BASED OUTPATIENT PROCEDURES 154
TABLE 170 BRAIN MONITORING MARKET FOR AMBULATORY SURGERY CENTERS & CLINICS, BY REGION, 2019–2026 (USD MILLION) 154
TABLE 171 NORTH AMERICA: BRAIN MONITORING MARKET FOR AMBULATORY SURGERY CENTERS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 155
TABLE 172 EUROPE: BRAIN MONITORING MARKET FOR AMBULATORY SURGERY CENTERS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 155
TABLE 173 APAC: BRAIN MONITORING MARKET FOR AMBULATORY SURGERY CENTERS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 155
8.5 DIAGNOSTIC CENTERS 156
8.5.1 DIAGNOSTIC CENTERS OFFER DIAGNOSIS AND TREATMENT OPTIONS FOR VARIOUS NEUROLOGICAL CONDITIONS 156
TABLE 174 BRAIN MONITORING MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2019–2026 (USD MILLION) 156
TABLE 175 NORTH AMERICA: BRAIN MONITORING MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 156
TABLE 176 EUROPE: BRAIN MONITORING MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 157
TABLE 177 APAC: BRAIN MONITORING MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 157
8.6 OTHER END USERS 157
TABLE 178 BRAIN MONITORING MARKET FOR OTHER END USERS, BY REGION,
2019–2026 (USD MILLION) 158
TABLE 179 NORTH AMERICA: BRAIN MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 158
TABLE 180 EUROPE: BRAIN MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 158
TABLE 181 APAC: BRAIN MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 159
9 BRAIN MONITORING MARKET, BY REGION 160
9.1 INTRODUCTION 161
TABLE 182 BRAIN MONITORING MARKET, BY REGION, 2019–2026 (USD MILLION) 161
9.2 NORTH AMERICA 161
FIGURE 28 NORTH AMERICA: BRAIN MONITORING MARKET SNAPSHOT 162
TABLE 183 NORTH AMERICA: BRAIN MONITORING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 162
TABLE 184 NORTH AMERICA: BRAIN MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 163
TABLE 185 NORTH AMERICA: BRAIN MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 186 NORTH AMERICA: BRAIN MONITORING DEVICES MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 163
TABLE 187 NORTH AMERICA: BRAIN MONITORING ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 188 NORTH AMERICA: BRAIN MONITORING ACCESSORIES MARKET, BY USABILITY, 2019–2026 (USD MILLION) 164
TABLE 189 NORTH AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2019–2026 (USD MILLION) 165
TABLE 190 NORTH AMERICA: BRAIN MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 165
9.2.1 US 165
9.2.1.1 The US dominates the North American brain monitoring market 165
TABLE 191 US: BRAIN MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 166
TABLE 192 US: BRAIN MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 193 US: BRAIN MONITORING DEVICES MARKET, BY PROCEDURE,
2019–2026 (USD MIL9.4 ASIA PACIFIC 187
TABLE 241 APAC: BRAIN MONITORING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 188
TABLE 242 APAC: BRAIN MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 188
TABLE 243 APAC: BRAIN MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 244 APAC: BRAIN MONITORING DEVICES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 189
TABLE 245 APAC: BRAIN MONITORING ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 246 APAC: BRAIN MONITORING ACCESSORIES MARKET, BY USABILITY,
2019–2026 (USD MILLION) 189
TABLE 247 APAC: BRAIN MONITORING MARKET, BY MEDICAL CONDITION,
2019–2026 (USD MILLION) 190
TABLE 248 APAC: BRAIN MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 190
9.4.1 JAPAN 190
9.4.1.1 High incidence of neurological disorders owing to the large geriatric population will drive market growth 190
TABLE 249 JAPAN: BRAIN MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 191
TABLE 250 JAPAN: BRAIN MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 251 JAPAN: BRAIN MONITORING DEVICES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 192
TABLE 252 JAPAN: BRAIN MONITORING ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 253 JAPAN: BRAIN MONITORING ACCESSORIES MARKET, BY USABILITY,
2019–2026 (USD MILLION) 192
TABLE 254 JAPAN: BRAIN MONITORING MARKET, BY MEDICAL CONDITION,
2019–2026 (USD MILLION) 193
TABLE 255 JAPAN: BRAIN MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 193
9.4.2 CHINA 193
9.4.2.1 China to register the highest growth in the brain monitoring market during the forecast period 193
TABLE 256 CHINA: BRAIN MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 194
TABLE 257 CHINA: BRAIN MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 258 CHINA: BRAIN MONITORING DEVICES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 195
TABLE 259 CHINA: BRAIN MONITORING ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 260 CHINA: BRAIN MONITORING ACCESSORIES MARKET, BY USABILITY,
2019–2026 (USD MILLION) 195
TABLE 261 CHINA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION,
2019–2026 (USD MILLION) 196
TABLE 262 CHINA: BRAIN MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 196
9.4.3 INDIA 196
9.4.3.1 Improving healthcare infrastructure in the country will support the growth of the brain monitoring market 196
TABLE 263 INDIA: BRAIN MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 197
TABLE 264 INDIA: BRAIN MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 265 INDIA: BRAIN MONITORING DEVICES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 197
TABLE 266 INDIA: BRAIN MONITORING ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 267 INDIA: BRAIN MONITORING ACCESSORIES MARKET, BY USABILITY,
2019–2026 (USD MILLION) 198
TABLE 268 INDIA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION,
2019–2026 (USD MILLION) 198
TABLE 269 INDIA: BRAIN MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 199
9.4.4 REST OF APAC 199
TABLE 270 ROAPAC: BRAIN MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 199
TABLE 271 ROAPAC: BRAIN MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 200
TABLE 272 ROAPAC: BRAIN MONITORING DEVICES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 200
TABLE 273 ROAPAC: BRAIN MONITORING ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 274 ROAPAC: BRAIN MONITORING ACCESSORIES MARKET, BY USABILITY, 2019–2026 (USD MILLION) 201
TABLE 275 ROAPAC: BRAIN MONITORING MARKET, BY MEDICAL CONDITION,
2019–2026 (USD MILLION) 202
TABLE 276 ROAPAC: BRAIN MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 202
9.5 REST OF THE WORLD 202
TABLE 277 ROW: BRAIN MONITORING MARKET, BY REGION, 2019–2026 (USD MILLION) 203
TABLE 278 ROW: BRAIN MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 203
TABLE 279 ROW: BRAIN MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 203
TABLE 280 ROW: BRAIN MONITORING DEVICES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 204
TABLE 281 ROW: BRAIN MONITORING ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 282 ROW: BRAIN MONITORING ACCESSORIES MARKET, BY USABILITY,
2019–2026 (USD MILLION) 204
TABLE 283 ROW: BRAIN MONITORING MARKET, BY MEDICAL CONDITION,
2019–2026 (USD MILLION) 205
TABLE 284 ROW: BRAIN MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 205
9.5.1 LATIN AMERICA 205
9.5.1.1 High cost of brain monitoring and imaging modalities to hamper market growth in this region 205
TABLE 285 LATIN AMERICA: BRAIN MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 206
TABLE 286 LATIN AMERICA: BRAIN MONITORING DEVICES MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 206
TABLE 287 LATIN AMERICA: BRAIN MONITORING ACCESSORIES MARKET, BY USABILITY, 2019–2026 (USD MILLION) 206
9.5.2 MIDDLE EAST & AFRICA 207
9.5.2.1 Strengthening of the healthcare infrastructure in the region to support market growth 207
TABLE 288 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 207
TABLE 289 MIDDLE EAST & AFRICA: BRAIN MONITORING DEVICES MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 208
TABLE 290 MIDDLE EAST & AFRICA: BRAIN MONITORING ACCESSORIES MARKET, BY USABILITY, 2019–2026 (USD MILLION) 208
10 COMPETITIVE LANDSCAPE 209
10.1 OVERVIEW 209
FIGURE 30 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES 209
10.2 MARKET SHARE ANALYSIS 210
FIGURE 31 BRAIN MONITORING MARKET SHARE, BY KEY PLAYER, 2020 210
10.3 COMPANY EVALUATION QUADRANT 211
10.3.1 STARS 211
10.3.2 EMERGING LEADERS 211
10.3.3 PARTICIPANTS 211
10.3.4 PERVASIVE PLAYERS 211
FIGURE 32 BRAIN MONITORING MARKET: COMPANY EVALUATION QUADRANT, 2020 212
10.4 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2020) 212
10.4.1 PROGRESSIVE COMPANIES 212
10.4.2 RESPONSIVE COMPANIES 212
10.4.3 STARTING BLOCKS 213
10.4.4 DYNAMIC COMPANIES 213
FIGURE 33 BRAIN MONITORING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020 213
10.5 COMPETITIVE BENCHMARKING 214
10.5.1 PRODUCT & REGIONAL FOOTPRINT OF COMPANIES 214
TABLE 291 OVERALL FOOTPRINT OF KEY PLAYERS 214
TABLE 292 REGIONAL FOOTPRINT OF KEY PLAYERS 214
TABLE 293 PRODUCT FOOTPRINT OF KEY PLAYERS 214
10.6 COMPETITIVE SITUATION AND TRENDS 215
10.6.1 PRODUCT LAUNCHES/ENHANCEMENTS AND APPROVALS 215
TABLE 294 BRAIN MONITORING MARKET: KEY PRODUCT LAUNCHES/ENHANCEMENTS AND APPROVALS 215
10.6.2 DEALS 216
TABLE 295 BRAIN MONITORING MARKET: KEY DEALS 216
10.6.3 OTHER DEVELOPMENTS 216
TABLE 296 BRAIN MONITORING MARKET: OTHER KEY DEVELOPMENTS 216
11 COMPANY PROFILES 217
(Business Overview, Products Offered, Recent Developments, MNM View, Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats)*
11.1 NATUS MEDICAL, INC. 217
TABLE 297 NATUS MEDICAL, INC.: BUSINESS OVERVIEW 217
FIGURE 34 NATUS MEDICAL, INC.: COMPANY SNAPSHOT (2020) 218
11.2 NIHON KOHDEN CORPORATION 221
TABLE 298 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 221
FIGURE 35 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2020) 221
11.3 PHILIPS HEALTHCARE 224
TABLE 299 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 224
FIGURE 36 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 225
11.4 GE HEALTHCARE 228
TABLE 300 GE HEALTHCARE: BUSINESS OVERVIEW 228
FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2020) 228
11.5 SIEMENS HEALTHINEERS 231
TABLE 301 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 231
FIGURE 38 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020) 232
11.6 COMPUMEDICS LIMITED 235
TABLE 302 COMPUMEDICS LIMITED: BUSINESS OVERVIEW 235
FIGURE 39 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2020) 235
11.7 MEDTRONIC PLC 239
TABLE 303 MEDTRONIC PLC: BUSINESS OVERVIEW 239
FIGURE 40 MEDTRONIC PLC: COMPANY SNAPSHOT (2020) 239
11.8 EDWARDS LIFESCIENCES CORPORATION 241
TABLE 304 EDWARDS LIFESCIENCES CORPORATION: BUSINESS OVERVIEW 241
FIGURE 41 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2020) 241
11.9 ADVANCED BRAIN MONITORING, INC. 243
TABLE 305 ADVANCED BRAIN MONITORING: BUSINESS OVERVIEW 243
11.10 DR?GERWERK AG & CO. KGAA 244
TABLE 306 DRAGERWERK AG & CO. KGAA: BUSINESS OVERVIEW 244
FIGURE 42 DR?GERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2020) 244
11.11 MASIMO CORPORATION 246
TABLE 307 MASIMO CORPORATION: BUSINESS OVERVIEW 246
FIGURE 43 MASIMO CORPORATION: COMPANY SNAPSHOT (2020) 246
11.12 SPIEGELBERG GMBH & CO. KG. 248
TABLE 308 SPIEGELBERG GMBH & CO. KG: BUSINESS OVERVIEW 248
11.13 CADWELL INDUSTRIES, INC. 249
TABLE 309 CADWELL INDUSTRIES, INC: BUSINESS OVERVIEW 249
11.14 NEUROWAVE SYSTEMS, INC. 250
TABLE 310 NEUROWAVE SYSTEMS, INC.: BUSINESS OVERVIEW 250
11.15 NEUROSOFT 251
TABLE 311 NEUROSOFT: BUSINESS OVERVIEW 251
11.16 CGX (A COGNIONICS COMPANY) 252
11.17 INTEGRA LIFESCIENCES 253
TABLE 312 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW 253
FIGURE 44 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020) 253
11.18 OTHER PLAYERS 255
11.18.1 NONIN 255
11.18.2 RIMED 255
11.18.3 EMOTIV 256
11.18.4 INFRASCAN, INC. 256
11.18.5 NEUSOFT MEDICAL SYSTEMS 257
11.18.6 CLINICAL SCIENCE SYSTEMS 258
11.18.7 NORAXON 258
11.18.8 STERNMED 259
*Details on Business Overview, Products Offered, Recent Developments, MNM View, Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats might not be captured in case of unlisted companies.
12 APPENDIX 260
12.1 DISCUSSION GUIDE 260
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 264
12.3 AVAILABLE CUSTOMIZATIONS 266
12.4 RELATED REPORTS 266
12.5 AUTHOR DETAILS 267